Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients

Clinical trial NCT05669833 · RECRUITING

Trial details

NCT number: NCT05669833
Sponsor: University of Pennsylvania
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Psoriatic Arthritis

Start date: 2023-07-14
Primary completion: 2026-10-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.